James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

ANF Stock Is Too Long on Risk, Too Short on Reward

Despite being down 65% since late 2011, ANF stock just isn't worth jumping into here.

5 ‘Double Threat’ Dividend Stocks That Offer Growth, Too

Dividends are nice, but dividend stocks that also offer growth potential leave nothing to be desired. Here are five stocks that offer both dividends and growth.

Why Denbury Resources, Freeport-McMoRan and Molson Coors Are 3 of Today’s Worst Stocks

Molson Coors Brewing Company, Denbury Resources and Freeport-McMoRan were the worst of the worst on Tuesday. Here's what investors need to know.

What Owners of CVS Stock Need to Know Before Tuesday’s Earnings Report

The CVS Health earnings report for Q4 of 2014 is due Thursday after the close. Here are three things owners of CVS stock need to know beforehand.

Why PVH, Century Aluminum and United Continental Holdings Are 3 of Today’s Worst Stocks

United Continental Holdings Inc., Century Aluminum Co. and PVH Corp. were Monday's biggest losers. Here's the deal.